{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:25:29Z","timestamp":1772915129179,"version":"3.50.1"},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T00:00:00Z","timestamp":1172102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2007,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND.<\/jats:title><jats:p>The clinical outcome and toxicity of fractionated stereotactic radiotherapy (FSRT) was assessed for acoustic neuroma in 60 patients treated in a single institution.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS.<\/jats:title><jats:p>Between October 1996 and February 2005, 60 patients received FSRT for acoustic neuroma (AN). The mean total dose applied was 50 Gy in single daily 2\u2010Gy fractions over 5 weeks. The median irradiated tumor volume was 4.9 cm<jats:sup>3<\/jats:sup> (range, 0.3\u201349.0 cm<jats:sup>3<\/jats:sup>). The median follow\u2010up period was 31.9 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS.<\/jats:title><jats:p>FSRT was well tolerated in all patients. The 5\u2010year actuarial local control rate was 96.2% (95% CI: 91.1%\u2013100.0%). Five\u2010year actuarial progression\u2010free survival was 92.8% (95% CI: 84.8%\u2013100.0%). The overall hearing preservation rate was 77.3%. Five of 6 patients with initial cranial nerve V (CNV) numbness remained stable post\u2010FSRT. Two of 3 patients with baseline trigeminal neuralgia improved with the remaining patient stable. All 3 patients with nonsurgically related facial nerve weakness either improved or achieved stability in function. There were no cases of new cranial nerve toxicity post\u2010FSRT.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS.<\/jats:title><jats:p>FSRT for the treatment of AN is safe, effective, and well tolerated. FSRT should thus be considered as an effective alternative treatment modality when compared with microsurgical resection or single fraction stereotactic radiosurgery. Cancer 2007. \u00a9 2007 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.22499","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T13:39:35Z","timestamp":1172151575000},"page":"1203-1210","source":"Crossref","is-referenced-by-count":63,"title":["Fractionated stereotactic radiotherapy for acoustic neuroma"],"prefix":"10.1002","volume":"109","author":[{"given":"Eng\u2010Siew","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara\u2010Ann","family":"Millar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Michaels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Heydarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenaz","family":"Ladak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Rutka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Guha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory R.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Normand J.","family":"Laperriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,2,22]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(02)02779-7"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2003.09.001"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.69.2.161"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200103000-00019"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00237-4"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.01.055"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.103.1.0053"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.102.s_supplement.0195"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.102.s_supplement.0087"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)00079-6"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000154736.38904.c3"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200503000-00011"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.2000.00317.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)01361-4"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000163091.12239.BB"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.04.017"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459988509300202"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348948809700110"},{"key":"e_1_2_5_20_2","volume-title":"Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTC"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90956-I"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000070106"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2007-027"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000169786.22707.12"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459980112400609"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199707000-00012"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2001.94.1.0061"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000172038.22929.63"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)00444-9"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(01)01559-0"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.02.019"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2001.95.3.0440"},{"key":"e_1_2_5_33_2","first-page":"927","article-title":"Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery","volume":"56","author":"Myrseth E","year":"2005","journal-title":"Neurosurgery."},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.102.1.0010"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.2310\/7070.2003.35371"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000166542.00512.84"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199701000-00002"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)00073-7"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000064809.59806.E8"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2001.94.5.0816"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/02688690050004480"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200501000-00018"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.22499","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.22499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:20:42Z","timestamp":1760300442000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.22499"}},"subtitle":["Single\u2010institution experience at the princess margaret hospital"],"short-title":[],"issued":{"date-parts":[[2007,2,22]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,3,15]]}},"alternative-id":["10.1002\/cncr.22499"],"URL":"https:\/\/doi.org\/10.1002\/cncr.22499","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,22]]}}}